Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Clonal Expansion Dynamics of the HIV-1 Reservoir: Mechanisms of Integration Site-Dependent Proliferation and HIV-1 Persistence. | Viruses | 2021 | 34578439 | PubTator, text mining | PubMed |
| New RNA-Based Breakthroughs in Alzheimer's Disease Diagnosis and Therapeutics. | Pharmaceutics | 2021 | 34575473 | PubTator, text mining | PubMed |
| NSD1: A Lysine Methyltransferase between Developmental Disorders and Cancer. | Life (Basel) | 2021 | 34575025 | PubTator, text mining | PubMed |
| Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma. | Cancers (Basel) | 2021 | 34572949 | PubTator, text mining | PubMed |
| Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment. | Cancers (Basel) | 2021 | 34572763 | PubTator, text mining | PubMed |
| VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles. | Biology (Basel) | 2021 | 34571765 | PubTator, text mining | PubMed |
| New Functions of Vav Family Proteins in Cardiovascular Biology, Skeletal Muscle, and the Nervous System. | Biology (Basel) | 2021 | 34571735 | PubTator, text mining | PubMed |
| Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies. | Nat Commun | 2021 | 34552085 | PubTator, text mining | PubMed |
| Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity. | PLoS Biol | 2021 | 34550965 | PubTator, text mining | PubMed |
| Quantitative proteomics identifies PTP1B as modulator of B cell antigen receptor signaling. | Life Sci Alliance | 2021 | 34526379 | PubTator, text mining | PubMed |
| Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravis. | Cell Discov | 2021 | 34521820 | PubTator, text mining | PubMed |
| Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications. | Mol Ther Oncolytics | 2021 | 34514097 | PubTator, text mining | PubMed |
| A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease. | Adipocyte | 2021 | 34506234 | PubTator, text mining | PubMed |
| TP53 in Biology and Treatment of Osteosarcoma. | Cancers (Basel) | 2021 | 34503094 | PubTator, text mining | PubMed |
| Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma. | Comput Math Methods Med | 2021 | 34497663 | PubTator, text mining | PubMed |
| Gata2 haploinsufficiency promotes proliferation and functional decline of hematopoietic stem cells with myeloid bias during aging. | Blood Adv | 2021 | 34496012 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Multifaceted Immunomodulatory Effects of the BTK Inhibitors Ibrutinib and Acalabrutinib on Different Immune Cell Subsets - Beyond B Lymphocytes. | Front Cell Dev Biol | 2021 | 34485307 | PubTator, text mining | PubMed |
| RNA m6A Modification Plays a Key Role in Maintaining Stem Cell Function in Normal and Malignant Hematopoiesis. | Front Cell Dev Biol | 2021 | 34485297 | PubTator, text mining | PubMed |
| Defining the RBPome of primary T helper cells to elucidate higher-order Roquin-mediated mRNA regulation. | Nat Commun | 2021 | 34471108 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=34